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Abstract We report on the development of an on-chip RPA
(recombinase polymerase amplification) with simultaneous
multiplex isothermal amplification and detection on a solid
surface. The isothermal RPA was applied to amplify specific
target sequences from the pathogens Neisseria gonorrhoeae,
Salmonella enterica and methicillin-resistant Staphylococcus
aureus (MRSA) using genomic DNA. Additionally, a positive
plasmid control was established as an internal control. The
four targets were amplified simultaneously in a quadruplex
reaction. The amplicon is labeled during on-chip RPA by
reverse oligonucleotide primers coupled to a fluorophore.
Both amplification and spatially resolved signal generation
take place on immobilized forward primers bount to expoxy-
silanized glass surfaces in a pump-driven hybridization cham-
ber. The combination of microarray technology and sensitive
isothermal nucleic acid amplification at 38 °C allows for a
multiparameter analysis on a rather small area. The on-chip
RPA was characterized in terms of reaction time, sensitivity
and inhibitory conditions. A successful enzymatic reaction is
completed in <20 min and results in detection limits of 10
colony-forming units for methicillin-resistant Staphylococcus
aureus and Salmonella enterica and 100 colony-forming units
forNeisseria gonorrhoeae. The results show this method to be
useful with respect to point-of-care testing and to enable
simplified and miniaturized nucleic acid-based diagnostics.
Keywords Isothermal amplification . RPA .Microchip .
DNA sensor . Point-of-care
Introduction
The amplification of a specific DNA sequence for the detec-
tion of a pathogen is a common tool in molecular diagnostics.
An established technique for nucleic acid amplification is the
polymerase chain reaction (PCR) [1, 2]. However the use of
this method in miniaturized lab on-chip devices for point-of-
care testing is challenging due to the high electricity demand
of the thermocycling process [3]. The design of portable and
automated systems for low-resource settings is limited as a
result of the high complexity of the reaction setup and the
precise temperature control necessary to conduct the
amplification.
A possible alternative to the PCR are isothermal nucleic
acid amplification techniques which are carried out at a single
temperature throughout the entire reaction using different
mechanisms e.g. the strand-displacement activity of certain
polymerases or the addition of further proteins used in the
natural replication processes [4]. Examples for isothermal
nucleic acid amplification techniques are the loop mediated
amplification (LAMP) [5], the helicase dependent amplifica-
tion (HDA) [6] the strand-displacement amplification (SDA)
[7] and the rolling circle amplification (RCA) [8] which have
been recently described and have already proven their use [9,
10]. Another promisingmethod is the recombinase polymerase
amplification (RPA) which uses a phage recombinase to direct
short oligonucleotide primers to a homologous target se-
quence. In combination with a strand displacing polymerase
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and a single-stranded DNA binding protein an amplification of
fewer than ten copies of genomic DNA can be accomplished in
less than 30min [11]. In addition the reaction runs at a constant
low temperature of about 37–39 °C and the PCR-like system
with only two primers offers the possibility for multiplex
assays. In the literature some RPA amplifications of different
DNA [11–13] and RNA [14–16] targets have been described.
So far, few applications of this method have been integrated in
more complex instrumentation as an approach for an improved
nucleic acid diagnosis in point of care testing [17–21].
In this work, we present the combination of microarray
technology and multiplex amplification with RPA. A multi-
plex RPA reaction was established amplifying different target
sequences of Neisseria gonorrhoeae, Salmonella enterica,
methicilin-resistant Staphylococcus aureus (MRSA) and of a
plasmid reaction control. Although these three pathogens are
not related, they do represent important targets for point-of-
care testing in the field of sexual-transmitted diseases (STD)
(Neisseria gonorrhoeae), food borne pathogens (Salmonella
enterica) and nosocomial infections (MRSA). The use of
specific sequences of these three pathogens as targets for the
amplification was not to address a clinical relevant question
but rather to demonstrate the strength of this method in a
highly parallel DNA analysis. Low-density microarrays have
already proven their ability as diagnostic tools [22–24] and
offer the possibility to test for multiple parameters on a small
surface area. Additionally they can serve as detection area in
microfluidic chips. The principle of oliognucleotide microar-
rays is the immobilization of short single stranded nucleic acid
probes and the subsequent hybridization of target molecules to
these probes. In previous work we demonstrated the combi-
nation of microarrays and enzymatic reactions directly on the
solid surface, using the probes as template for the enzymes
and thus reducing the steps for the diagnostic microarray. PCR
[25], RT-PCR [26], the transcription of a whole gene [25] and
the isothermal OnChip-HDA [27] on solid surfaces have been
described. Solid phase amplification can successfully mini-
mize the formation of primer dimers and thus reduce non-
specific products [28] especially during the amplification of
multiple targets in parallel where a mixture of different oligo-
nucleotide primers is used.
In our approach the asymmetric RPA is carried out directly
on the surface. A labeling of the RPA product is achieved by
using a Cy5-fluorophor-modified reverse primer. During the
on-chip RPA the amplification in solution as well as the solid
phase amplification and hybridization are taking place at the
same time in a hybridization chamber with automatic pumps
at 38 °C. Successfully amplified products can be detected
spatially-resolved by laser scanner or TIRF measurements.
To our knowledge this highly multiplex pathogen detection
is the first combination of isothermal RPA and microarray
technology and offers new possibilities for the development of
point-of-care testing devices for nucleic acids.
Experimental
Materials and primer design
Oligonucleotide primer and probes used in this study were
synthesized by biomers.net (Ulm, Germany, www.biomers.
net). For RPA reactions the TwistAmp™ basic kit was
purchased from TwistDx (Babraham, UK, www.twistdx.co.
uk). Betaine was obtained from Sigma (Schnelldorf, Germany,
www.sigmaaldrich.com). Genomic DNA of Neisseria
gonnorhoeae (DSM9188) was purchased from DSMZ
(Braunschweig, Germany, www.dsmz.de). Salmonella
enterica (DSM14221) and methicillin-resistant Staphylococ-
cus aureus (ATCC43300) were extracted using the GeneJET
Genomic DNA Purification Kit (ThermoScientific, Waltham,
USA, www.thermoscientificbio.com). Quantity and quality of
the extracted DNA was determined by measuring A260 and
the ratio of A260/A280 on a Nanodrop ND-1000 spectropho-
tometer (ThermoScientific, Wilmington, USA, www.
nanodrop.com). Primers were designed with parameters
according to the TwistDx instruction manual and Primer-
BLAST available at http://www.ncbi.nlm.nih.gov/tools/
primer-blast/ combining Primer3 and BLAST global
alignment. Primer dimerization was tested with AutoDimer
[29].
RPA reactions
For the primer evaluation and the optimization of multiplex
RPA reactions an extensive testing in solution was carried out
before on-chip assays. A typical RPA reaction in a 50 μL
volume contained 480 nMRPA primers, 0.5M betaine and 1x
rehydration buffer. This mastermix was used to rehydrate the
freeze-dried reaction pellet and 14 mM Magnesium acetate
was added to the solution to initiate the reaction. The reaction
was kept at 38 °C for 40 min on a thriller thermoshaker-
incubater (PEQLAB Biotechnologie GMBH, Erlangen, Ger-
many, www.peqlab.de). Subsequently, amplification products
were cleaned-up with the QIAquick PCR Purification Kit
(Qiagen, Hilden, Germany, www.qiagen.com) and analyzed
on 3 % ethidium-bromide agarose gel with the molecular
weight marker HyperLadder V (Biol ine GmbH,
Luckenwalde, Germany, www.biol ine.com) in a
BioDocAnalyze imagine system (Analytik Jena AG, Jena,
Germany, www.analytik-jena.de). For multiplex experiments
primer concentration were adjusted to the following: 360 nM
Neisseria gonnorhoeae; 340 nM Salmonella enterica; 300 nM
MRSA and plasmid control. Methicillin-resistant Staphylo-
coccus aureus (MRSA) was detected by amplifying a
193 bp fragment of mecAwhich gene product is responsible
for the resistance against penicillin-like antibiotics. A 133 bp
product of the invA gene was amplified in Salmonella
enterica. InvA is an important virulence factor, necessary for
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the invasion of cells in the intestinal epithelium and is specific
for Salmonella spp. [31]. For Neisseria gonnorhoeae the fit-
gene (fast intracellular trafficker) was chosen as target for the
RPA [32], resulting in a 165 bp amplicon. In order to verify a
successful amplification of the RPA reaction in a future diag-
nostic device the amplification of a 227 bp long fragment of a
plasmid control was additionally established. All primers used
in this study can be found in Table 1.
Preparation of biochips
As a solid support, in-house produced epoxy-silanated glass
slides were used. Amino-modified oligonucleotide probes
were spotted at a concentration of 15 μM in 3xSSC buffer
with a Topspot Microarray Printer (BioFluidix GmbH, Frei-
burg, Germany, www.biofluidix.com). In total nine 6×4
subarrays were spotted on each slide (Fig. 1) with an
approximate distance of 500 μM between individual spots.
Several controls were incorporated in the assay including a
specificity control (35 mer oligonucleotide with no sequence
homologies) , an immobil izat ion control (15mer
oligonucleotide with 5′-Cy5-modification) and spotting
controls (spotting buffer). The biochips were incubated over
night at 25 °C and 75 % air humidity in a climate chamber
(Binder, Tuttlingen, Germany, www.binder-world.com).
Before on-chip RPA reactions the glass slides were blocked
in Thermo Scientific SuperBlock Blocking Buffer (Waltham,
USA, www.thermoscientificbio.com) at room temperature for
1 h.
On-chip RPA
On-chip experiments were performed in a programmable
hybridization chamber (Epigenomics, Berlin, Germany,
www.epigenomics.com). Each of the chambers has
adjustable temperature properties and individually selectable
pumps. For an improved hybridization to the immobilized
probes an asymmetric RPA was carried out with the reverse
primer concentrations being ten times higher than forward
primers. RPA reactions on-chip contained Cy5-labeled reverse
primers otherwise the concentration of RPA in solution exper-
iments were used. At a constant temperature of 38 °C the
reaction was permanently pumped in the reaction chamber
with a volume of 8.3 μL at a pump frequency of 2.8 s per
stroke for a typical 40 min. After the RPA reaction on the
chips and automated washing step was initiated washing the
chips three times for 5 min at RT with decreasing concentra-
tion of SSC. Awash step with 2xSSC buffer was followed by
a second washing step containing 1xSSC and the final wash
step comprised of 0.2xSSC buffer. At the end the slides were
dried under a stream of nitrogen.
Read-out and data-analysis
After the on-chip RPA reactions the biochips were read out in
an Axon Genepix Professional 4200A microarray scanner
(Sunnyvale, CA, USA, www.moleculardevices.com) and
data analysis was performed with Genepix 6 software
(MDS, Sunnyvale, USA, www.moleculardevices.com). Each
signal is defined as the integral of the fluorescence intensity
over the whole spot. Contrasts for each fluorescence spot
signal were calculated according to the formula:
C ¼ 100 S−Bgð Þ
Sþ Bgð Þ
Where C is the contrast value (in %), S is the primary
fluorescence signal and Bg is the average fluorescence signal
of the specificity and the negative controls of the individual
Table 1 Primers used in this study
Target gene Oligonucleotide sequence [5′-3′] Amplicon length
Staphylococcus aureus (MRSA)
SA fwd3 mecA TCCAACATGAAGATGGCTATCGTGTCACAATCGTT 193 bp
SA rev3 CCTGTTTGAGGGTGGATAGCAGTACCTGAGCC
Salmonella enterica
SE fwd1 invA TACCGGGCATACCATCCAGAGAAAATCGGGCCGC 133 bp
SE rev2 ATTGGCGATAGCCTGGCGGTGGGTTTTGTTGT
Neisseria gonorrhoeae
NG fwd3 fit CAACGCAATCAAATTCCGTGCGCGAGCCGCAG 165 bp
NG rev2 CCGCGTACGTCTTCCAGCTCAACACCTCCGAT
Plasmid control
PC fwd5 Plasmid control ATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGT 227 bp
PC rev6 CAGCAACGCGGCCTTTTTACGGTTCCTGGCCTT
For on-chip RPA experiments forward primers were modified with a 5′NH2-(CH2)6-linker to allow the covalent attachment to the chip surface. Reverse
primers in on-chip RPA experiments contain a 5′ Cy5-modification for signal generation
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chip used. In order to verify the results a limit of detection was
calculated according to the formula





 þ Bg 
where SDBg is the standard deviation of the background
signal.
Result and discussion
Optimization of RPA and multiplex RPA development
In the isothermal RPA a phage derived recombinase in com-
bination with a co-factor form a complex with oligonucleotide
primers which then can be directed to homologeous sequences
in a DNA template. Subsequently amplification takes place
using a strand-displacement polymerase and single-strand
binding proteins (SSB) (Fig. 2a). The uniform isothermal
reaction at a temperature of 37–39 °C and the use of only
two primers are advantageous, yet regular PCR primers are
unlikely to work in the RPA [30]. For this reason several
primer combinations were initially evaluated for each patho-
genic target sequence in singleplex reactions and tested for
sensitivity and specificity. Each RPA primer pair generated a
product that was distinct in size in order to enable the inter-
pretation of amplification results on an agarose gel. The
amplification of multiple DNA targets in the same reaction
has the advantage to gain more information from one sample
and thus reduce time and costs for every diagnosis since no
parallel experiments are necessary to be conducted. So far
most isothermal nucleic acid amplification techniques are
usually limited to amplify only one target sequence. In the
RPA two primers are needed for a successful amplification
whereas e.g. the LAMP–technique typically uses six primers.
Hence a higher multiplexing ability can be assumed for the
RPA. Various primer mixtures and concentrations as well as
reaction conditions were evaluated and optimized for the
multiplex experiments. In Fig. 3 all simplex and the multiplex
detection are visualized on an ethidium-bromide stained aga-
rose gel and the specific amplification with RPA can be
determined by the size of the product. All RPA reactions were
run at 38 °C for 40 min with 250 pg of genomic DNA and
subsequently purified with spin columns. In the quadruplex
reaction clearly distinguishable bands of the expected product
sizes are observable with no specific band in the no template
control (NTC). Albeit the brightness of all bands shows al-
most the same intensity, minor differences are noticeable.
Amplification efficiency in a multiplex amplification assay
highly depends e.g. on the target sequence, amplicon size or
primer characteristics and has to be optimized for every new
multiplex approach.
On-chip RPA
For point-of-care testing devices the use of agarose gel elec-
trophoresis is not feasible. In the particular case of the RPA,
crowding agents and proteins in the reaction can interfere in
the run of gels. Therefore amplification products have to be
cleaned up before use. This additional step can be very time
consuming and requires additional equipment. The on-chip
RPA reaction has the benefit that no preliminary preparation
steps are necessary before detection. In Fig. 2b the process of
the on-chip amplification is described. Herein gene-specific
forward primers are covalently immobilized on the solid
glass-support using microarray spotting technology. The oli-
gonucleotides are modified with an amino group and bind to
the epoxy silanized glass slides. The asymmetric RPA reaction
takes place in the solution above the surface inside of an
automated hybridization chamber (Fig. 3c). Additionally to
the reaction components the solution consists of the Cy5-
modified reverse primer and, at a tenfold lower concentration,
the forward primer. Our observation shows that an amplifica-
tion under asymmetric primer conditions is conducive to the
reaction and enhances the signal significantly. Especially
when only low amounts of target DNA are present. For this
reason we conclude that two mechanisms play a role in the
signal generation in our on-chip RPA experiments. (i) The
Fig. 1 Array layout for on-chip RPA experiments. Each subarray con-
sists of 24 spots. In total nine of these subarrays were spotted on each
slide. All subarrays contained target specific oligonucleotides for on-chip
amplification and hybridization and different types of controls: Specific-
ity control (SC), buffer control (BC) and immobilization control (IC)
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excess of reverse primer in the reaction and the subsequent
polymerase elongation leads to a preferred amplification of a
single strand antisense DNA strand which can hybridize to the
target specific probe structure on the surface. During the
amplification reaction labeled primers are integrated in the
amplicon. The product can then be detected spatially-
resolved on the surface. (ii) The immobilized primer can serve
as starting point for solid-phase isothermal amplification. A
complex is formed between the recombinase and the primer
which then can bind to the template DNA and lead to a strand
exchange. In the following the polymerase elongates the
strand and releases the target DNA which results in an
exponential amplification of the DNA molecules. The reverse
primer in solution with the fluorophor dye can hybridize to the
immobilized strand and also functions as starting point for the
polymerase. Both solid-phase and solution-based amplifica-
tion lead to a signal generation which can be read out
(Fig. 3b). In other solid-phase amplification assays with an
improved surface-to-volume ratio, for example in reduced
volumes or with three dimensional surface structures, the rates
of these two mechanisms might be altered and the solid-phase
amplification might be preferred. In the Figures S2a-d (Elec-
tronic Supplementary Material) the singleplex on-chip RPA
reactions using 250 pg of genomic DNA of the three
Fig. 2 Principle of labeling RPA, on-chip RPA and photograph of one
programmable hybridization chamber. a Schematic reaction mechanism
of the labeling RPA in solution: two oligonucleotide primers form a
complex with a recombinase (green ovals) and are directed to homolo-
gous sequences on the target sequence were they are able to invade the
DNA double strand. The polymerase (blue) elongates the strand leading
to duplication. RPA runs continuously at 38 °C. A labeling of the
amplification product is achieved by using a reverse primer coupled with
a Cy5 reporter dye (red). b Two mechanisms for signal generation during
the on-chip RPA. (i) Single-stranded and labeled amplicons from asym-
metric RPA in solution above the biochip can hybridize specifically to
immobilized forward primers. (ii) The forward primer attached to the
surface serves as starting point for solid-phase RPA c Photograph of one
chamber in the programmable hybridization station used for on-chip RPA
experiments. The chamber is temperature adjustable and features an
individually programmable pump-driven mixing system (not in the pic-
ture) with a reaction volume of 45 μL. Slides placed in the chamber are
sealed with a silicone o-ring
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pathogens or 250 pg of plasmid DNA for the control plasmid
with a reaction time of 40 min are shown. Only at positions
where the specific target sequence is located a fluorescence
signal can be observed in the laser scanning images. Other
spots on the chip with either different target specific probes,
non homologous negative controls or spotting controls show
no increased signal. The specificity and the successful ampli-
fication were also verified using the quantitative data of the
signal intensities to calculate an individual limit of detection
(LOD) for every experiment. The resulting analysis displays a
good correlation to the qualitative data, showing in all assays
signal intensities above the LOD for the specific amplification
site while the integrated control spots do not exhibit an en-
hanced signal. Variations in the LOD are due to differences in
background intensity on parts of the slides which increase the
standard deviation of the background signal. However all
signals generated by the on-chip RPA are highly specific and
distinguishable from unspecific background noise.
In the next step we transferred the multiplex RPA to the on-
chip amplification. Herein all four targets were amplified in
parallel by mixing all reaction components and the gene-
specific primers in the programmable hybridization chamber.
The fluorescence image shows a successful amplification of
all targets, while no significant signal can be observed at the
sites of negative and specificity controls (Fig. 4). Albeit the
high background noise which increased the LOD in the quan-
titative analysis, all amplified targets have a signal above the
calculated value while in the negative controls almost no
signal can be detected. The signal of Salmonella enterica is
only narrowly above the LOD which is due to a high signal
variance distributed over the biochip. Control experiments
with no template show no signal in both qualitative and
quantitative analysis (Figure S1e Electronic Supplementary
Material). An improved blocking procedure might decrease
the signal variation by preventing unspecific binding to the
chip surface. The high total amount of fluorophor-labeled
reverse primer in multiplex reaction does also increase the
background signal. Concentrations of these primers might be
reduced, but minimum concentrations for the multiplex ex-
periments without decreasing the amplification efficiency
have yet to be defined.
A solid-phase based amplification with immobilized
primers has the advantage of potentially reducing non specific
product formation for example by primer-dimerization. In our
assay a total number of eight oligonucleotides are used in the
on-chip reaction. Because of the asymmetric conditions of the
assay only low amounts of forward primers remain in the
solution while the others are bound to the surface and cannot
interfere with the reaction. The attenuation of possible unspe-
cific byproducts is a crucial factor for isothermal nucleic acid
amplification methods and in particular for those working at
lower temperatures like the RPAwhere mismatches are more
likely to occur. In this study we demonstrated an approach to
overcome these problems by solid-phase amplification and
space-resolved detection.
Evaluation of reaction conditions
The reaction speed for diagnostic test is of crucial importance.
The high sensitivity of nucleic acid amplification techniques
like the PCR improve the time to result excessively since these
methods usually do not require a precultivation of the patho-
gen. However the PCR still might take hours to be completed
when manual prepreparation steps and the analysis procedure
are taken into account. In recent years many efforts have been
made to improve the speed of the PCR for example with
optimized enzymes and highly sophisticated equipment. Yet
these instruments are expensive and usually remain laboratory
bound. We tested the speed of the on-chip RPA with 1 ng of
genomic DNA of Salmonella enterica and stopped the reac-
tion at 0, 5, 10, 20 and 30min by starting the washing process.
The results are pictured in Fig. 5 demonstrating the fast
isothermal amplification reaction. Stable signals at
Salmonella-specific immobilized primers were observed after
20min reaction timewith no unspecific or cross amplification.
Even after 10 min positive signals were obtained but in this
experiment the signal was not evenly distributed over the
entire slide. Therefore a high difference in signal intensities
is measured. The only partial mixing of the reaction compo-
nents in the reaction chamber could be the reason for this
occurrence. Although none of the other amplification reac-
tions were tested in the on-chip RPA, the results from the
Fig. 3 Agarose gel electrophoresis (3 %) with all singleplex and multi-
plex RPA reactions after clean-up, using 250 pg of genomic or plasmid
DNA. Amplified products can be identified by size: Salmonella enterica
(133 bp) Neisseria gonnorhoeae (165 bp), methicillin-resistant Staphylo-
coccus aureus (MRSA) (193 bp) and plasmid control (227 bp). A suc-
cessful quadruplex RPA is indicated by the four distinct bands visible,
while in the no-template control (NTC) no specific band is present.
M = Molecular weight marker HyperLadder V (Bioline)
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primer optimization and evaluation in solution with real-time
quantitative detection indicate that the time ranges are similar
for all used primer combinations. A stable amplification reac-
tion can be achieved in less than 20 min. Combined with the
subsequent washing step of 15 min and the manual set-up
work, the on-chip RPA can be performed within 60 min. At
present, external sample preparation steps are time consuming
and add up to the total reaction time. A fully automated system
could significantly reduce the hands-on time andmake the fast
on-chip RPA reaction suitable for point-of-care testing where
a rapid test result is desired.
The analytical sensitivity of a diagnostic device is an es-
sential criterion. In biological or clinical samples only low
amounts of target organisms might be present. Nucleic acid
amplification techniques can theoretically detect one single
target molecule, or if a target with higher copy number is
addressed also one pathogenic organism. RPA has been de-
scribed in literature to be able to amplify around 10 copies of
genomic DNA [11]. We tested the sensitivity of the on-chip
RPAwith a serial dilution of genomic DNA from methicillin-
resistant Staphylococcus aureus ranging from 106 to 1 colony
forming units (CFU). Each reaction was run for 40 min in the
hybridization chamber. We observed an increase in signal
intensities in the on-chip RPA with 10 copies of genomic
DNA (Figure S2 Electronic Supplementary Material) making
it a highly sensitive method for nucleic acid detection. With
100 copies a stable signal well above the calculated LOD is
detectable. The amplification of 103 copies shows a clearly
positive amplification in the qualitative data of the laser scan.
However the quantitative analysis of the data leads to signals
just above the LOD resulting from a high, but constant,
background signals throughout the slide and thus leading to
a relatively low LOD but also equivalent small MRSA-
specific contrast values in this assay. Again, an optimization
of blocking conditions and washing procedure is necessary to
avoid possible misinterpretations and to allow a more constant
quantification of the results from on-chip RPA experiments.
Similar sensitivities of 10 copies (S.enterica and plasmid
control) or 100 copies (N. gonorrhoeae) can be achieved with
other RPA amplification used in this approach.
On-chip RPA reactions were additionally tested in complex
samples. For enzyme based nucleic acid amplification tech-
niques methods certain inhibitory substances e.g. hemoglobin,
salts or detergents are known. These might be part of a
biological sample or can be introduced during the preparation
or analysis in the sampling process [33]. The targeted organ-
isms in this assay are usually obtained from nasal (Staphylo-
coccus aureus), vaginal or cervical (Neisseria gonorrhoeae)
swabs, stool, urine, blood or environmental samples (Salmo-
nella enterica). All these samples and necessary extraction
methods result in specimens containing substances which may
block nucleic acid amplification either by inhibiting enzyme
Fig. 4 Quadruplex on-chip RPA experiment for the detection of
methicilin-resistant Staphylococcus aureus (MRSA), Neisseria
gonorrhoeae (NG), Salmonella enterica (SE) and a plasmid (amplifica-
tion control) (PC) in parallel. Laser scanner images of one subarray (left
side) showing clearly visible signals at positions where amplification-
specific sequences are immobilized (compare with Fig. 1). Quantitative
analysis (right side) exhibit signals well above the dynamic limit of
detection (LOD) (horizontal line), while no signals above LOD occur in
non-specific or buffer control positions. IC: immobilization control; BC:
buffer control; SC: specificity control
Fig. 5 Determination of the reaction time for on-chip RPA experiments
showing a signal after 20 min of isothermal amplification for the specific
detection of Salmonella enterica. After 10 min also target specific signals
are visible but are not constant across the whole slide resulting in a high
standard derivation. Dark grey: Independently calculated dynamic LOD
for every assay. Light grey: Signal for Salmonella enterica-specific posi-
tions on slides
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activity (directly or by the interaction with cofactors) or
forming complexes with the target DNA. Furthermore a high
amount of background DNA e.g. human DNA or human cell
material in clinical samples might also interfere with the
reaction. In order to test a possible influence on the on-chip
RPA 1 ng of genomic DNAof Salmonella entericawas spiked
into 1 μg and 10 μg of salmon sperm DNA, or 1 ng of
Neisseria gonorrhoeae genomic DNAwas spiked into a crude
lysate of 2×104 Jurkat cells. RPA reactions were run accord-
ing to the protocol. The results show no significant reduction
of signal (Figure S3 Electronic Supplementary Material) in
comparison to other on-chip RPA experiments with signals
well over the individual determined LODs. These promising
results indicate that the RPA might also run in a complex
matrix, crude samples or only partially cleaned up specimen.
Yet further tests need to determine the inhibitory concentra-
tions for relevant substances for a point of care testing
application.
Conclusion
We described the combination of isothermal nucleic acid
amplification with RPA and detection on immobilized probes.
The ability to detect multiple targets in the same reaction was
successfully demonstrated with the parallel amplification of
three different pathogens and a plasmid reaction control. The
multiplex amplification was transferred to on-chip RPA assays
were the labeled amplification product was analyzed spatially-
resolved on a biochip surface manufactured with microarray
technology. The on-chip RPA could extend the possibility to
detect and analyze nucleic acids in a POC testing device.
Without the need for the thermocycling process these devices
could be simplified and would not require expensive addition-
al equipment and thus reduce the overall diagnostic costs. Our
results show that the on-chip RPA is considerably faster than
common PCR techniques. We demonstrated that a time to
result in less than 20 min is feasible. At the same time no loss
in sensitivity and specificity in comparison with other diag-
nostic systems can be observed. The use of a solid phase for
the detection and amplification allows the parallel analysis of
the products on a small surface area and could allow the
integration in a microfluidic lab-on-chip device. Yet further
optimization of the assay is necessary and the adaptation of the
on-chip RPA to a relevant analytical question and the evalu-
ation with clinical samples is considered. By targeting multi-
ple genes at once the on-chip RPAwould allow to test e.g. for
a panel of infectious pathogens associated with a particular
clinical manifestation in a single experiment. In combination
with sample preparation and DNA isolation a true field test for
nucleic acids could be established with a potential quantitative
real-time read-out.
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